Home Search Abstracts Browse Oral Sessions Browse Poster Sessions Webcasts and Podcasts

 

Session 8  Oral Abstracts
New Insights into Transmission and Disease Progression
Monday, 10 am - 12:30 pm
Room: Ballroom 7-8

Moderators:

  Carol Ciesielski
  Chicago Dept of Publ Hlth, IL, US

  Robert Horsburgh
  Boston Univ Sch of Publ Hlth, MA, US
10:00 am         25 Routine HIV Testing in Botswana: A Population-based Study on Attitudes, Practices, and Human Rights Concerns
Sheri Weiser*1, M Heisler2, K Leiter3, F Percy-De Korte3, S Tlou4, S Demonner2, N Phaladze4, D Bangsberg5, and V Iacopino3
1Ctr for AIDS Prevention Studies, Univ of California, San Francisco, US; 2VA Ann Arbor Hlth System, Univ of Michigan Sch of Med, US; 3Physicians for Human Rights, Cambridge, MA, US; 4Univ of Botswana, Gaborone; and 5San Francisco Gen Hosp, Univ of California, US
10:15 am         26 HLA-B Bw4 and Bw6 Alleles and Risk for HIV-1 Transmission in HIV-serodiscordant Heterosexual Couples
Tania Welzel*1, X Gao2, R Pfeiffer1, M Martin2, J Goedert1, M Carrington2, and T O'Brien1
1NCI, NIH, DHHS, Bethesda, MD, US and 2NCI, Frederick, MD, US
10:30 am         27 Trends in HIV Diagnosis among Non-Hispanic Black Americans, 2001-2004
Tonji Durant*, A Satcher, J Prejean, X Wei, and L Lee
CDC, Atlanta, GA, US
10:45 am         28 High HIV Prevalence and Incidence Observed among African-American Men who have Sex with Men (MSM) in Baltimore: The Behavioral Surveillance Research (BESURE) Study
Frangiscos Sifakis*1, C Flynn2, R Montes De Oca1, M Hilton1, N Tomoyasu2, and D Celentano1
1Johns Hopkins Univ, Bloomberg Sch of Publ Hlth, Baltimore, MD, US and 2Maryland Dept of Hlth and Mental Hygiene, Baltimore, US
11:00 am         29 Non-AIDS Related Mortality Risk Exceeds AIDS-related Mortality among Injecting Drug Users with CD4+ Counts above 200 Cells/mm3
Bryan Lau*1,2, S Gange2, and R Moore1,2
1Johns Hopkins Univ, Baltimore, MD, US and 2Johns Hopkins Univ, Bloomberg Sch of Publ Hlth, Baltimore, MD, US
11:15 am         30 Primary Causes of Mortality in HIV Discordant Zambian Couples
Philip J Peters*1,2, I Zulu1,3, N Kancheya1,3, S Lakhi1,3, E Chomba1,3, D J Kim1,4, I Brill1,4, J Meinzen-Derr1,4, A Fraser-Bell1,5, and S Allen1,5,6
1Rwanda-Zambia HIV Res Group; 2Emory Univ Sch of Med, Atlanta, GA, US; 3Univ Teaching Hosp, Lusaka, Zambia; 4Univ of Alabama at Birmingham, US; 5Emory Rollins Sch of Publ Hlth, Atlanta, GA, US; and 6Emory AIDS Intl Training and Res Prgm, Atlanta, GA, USA
11:30 am    31LB National HIV Prevalence and BED HIV Incidence Estimates: South Africa 2005
Thomas Rehle*1, A Puren2, K Zuma1, V Pillay1, P Dana1, and O Shisana1
1Human Sci Res Council, Cape Town, South Africa and 2Natl Inst for Communicable Diseases, Johannesburg, South Africa
11:45 am    32LB Prevention of Rectal SHIV Transmission in Macaques by Tenofovir/FTC Combination
J Garcia-Lerma, R Otten, S Qari, E Jackson, W Luo, M Monsour, R Schinazi, R Janssen, T Folks, and Walid Heneine*
CDC, Atlanta, GA, US
12:00 pm    33LB Effect of HSV-2 Suppressive Therapy on HIV-1 Genital Shedding and Plasma Viral Load: A Proof of Concept Randomized Double-Blind Placebo Controlled Trial (ANRS 1285 Trial)
Nicolas Nagot*1,2, A Ouedraogo2, P Mayaud1, I Konate2, L Vergne2, H Weiss1, V Foulongne3, D Djagbare2, M Segongy3, P Vande Perre3, and ANRS 1285 Study Group
1London Sch of Hygiene and Tropical Med, UK; 2Ctr Muraz, Bobo-Dioulasso, Burkina Faso; and 3Univ Hosp, Montpellier, France
12:15 pm  34LBa Association between Genital Schistosomiasis and HIV in Rural Zimbabwean Women
Eyrun F Kjetland*1, P Ndhlovu2,3, T Mduluza2,3, E Gomo2,3, N Midzi3, L Gwanzura2, P Mason2,4, L Sandvik5, H Friis6, and S Gundersen7
1Ctr for Imported and Tropical Diseases, Ulleval Univ Hosp, Oslo, Norway; 2Coll of Hlth Sci, Univ of Zimbabwe, Harare; 3Blair Natl Inst of Hlth Res, Zimbabwe; 4Biomed and Res Training Inst, Harare, Zimbabwe; 5Competence Ctr for Clin Res, Ulleval Univ Hosp, Oslo, Norway; 6Inst of Publ Hlth, Univ of Copenhagen, Denmark; and 7Sorlandet Hosp HF, Agder Univ Coll, Kristiansand, Norway
12:30 pm  34LBb Investigation of Reports of Excessive False-positive Oral Fluid Rapid HIV Tests
Bernard Branson*1, L Wesolowski1, K Delaney1, M Mavinkurve2, T Dowling3, and D Mackellar1
1CDC, Atlanta, GA, US; 2New York City Dept of Hlth and Mental Hygiene, NY, US; and 3San Francisco Dept of Publ Hlth, CA, US